Search

everythinglearnresearchcommunity

for

Search:↓

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

Different types of sun exposure damage skin cells and immune cells, with chronic exposure leading to more severe and lasting damage.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Different types of sun exposure can damage skin cells and affect healing, with chronic exposure being more harmful, and certain immune cells help in the repair process.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

Certain immune responses may cause ongoing COVID-19 symptoms like fatigue and brain fog.

Stress can cause hair loss and trigger autoimmunity by damaging hair follicle cells.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

UV exposure harms skin by causing fibroblast loss, but T cells help fibroblast survival.

Cell therapy is advancing with stem cell transplants and genetically modified cells improving treatment for diseases like cancer and autoimmune disorders.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

FOXN1 gene variants cause low T cells and immune issues from birth.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.